High tumour cannabinoid CB1 receptor immunoreactivity negatively impacts disease-specific survival in stage II microsatellite stable colorectal cancer.

<h4>Background</h4>There is good evidence in the literature that the cannabinoid system is disturbed in colorectal cancer. In the present study, we have investigated whether CB(1) receptor immunoreactive intensity (CB(1)IR intensity) is associated with disease severity and outcome.<h4...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sofia B Gustafsson, Richard Palmqvist, Maria L Henriksson, Anna M Dahlin, Sofia Edin, Stig O P Jacobsson, Åke Öberg, Christopher J Fowler
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2011
Materias:
R
Q
Acceso en línea:https://doaj.org/article/2f94b9e5d28d4124b610b54a3ffed347
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!